| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $307.39B | +8.7% |
| Cost of Revenue | $133.33B | +5.6% |
| R&D Expense | $45.43B | +15.0% |
| SG&A Expense | $16.43B | +4.5% |
| Operating Income | $84.29B | +12.6% |
| Interest Expense | $308.0M | -13.7% |
| Pre-tax Income | $85.72B | +20.2% |
| Income Tax | $11.92B | +5.0% |
| Net Income | $73.80B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.05B | +9.9% |
| Short-term Investments | $86.87B | -5.5% |
| Accounts Receivable | $47.96B | +19.1% |
| Current Assets | $171.53B | +4.1% |
| Total Assets | $402.39B | +10.2% |
| Current Liabilities | $81.81B | +18.1% |
| Long-term Debt | $14.86B | -2.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $101.75B | +11.2% |
| Capital Expenditures | $32.25B | +2.4% |
| Investing Cash Flow | -$27.06B | -33.3% |
| Financing Cash Flow | -$72.09B | -3.3% |
| Free Cash Flow | $69.50B | +15.8% |
| +23.0% |
| EPS (Basic) | $5.84 | +27.2% |
| EPS (Diluted) | $5.80 | +27.2% |
| Total Liabilities |
| $119.01B |
| +9.1% |
| Stockholders' Equity | $283.38B | +10.6% |